Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 115

1.

A vaginal nanoformulation of a SphK inhibitor attenuates lipopolysaccharide-induced preterm birth in mice.

Giusto K, Patki M, Koya J, Ashby CR Jr, Munnangi S, Patel K, Reznik SE.

Nanomedicine (Lond). 2019 Nov;14(21):2835-2851. doi: 10.2217/nnm-2019-0243. Epub 2019 Nov 15.

PMID:
31793846
2.

Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.

Narayanan S, Cai CY, Assaraf YG, Guo HQ, Cui Q, Wei L, Huang JJ, Ashby CR Jr, Chen ZS.

Drug Resist Updat. 2019 Nov 11;48:100663. doi: 10.1016/j.drup.2019.100663. [Epub ahead of print]

PMID:
31785545
3.

Oral and dermal toxicity of alkenones extracted from Isochrysis species.

McIntosh K, Sarver J, Mell K, Terrero DJ, Ashby CR Jr, Reddy ', Neil GO, Ramapuram JB, Tiwari AK.

Front Biosci (Landmark Ed). 2020 Jan 1;25:817-837.

PMID:
31585919
4.

Pharmaceutical Topical Delivery of Poorly Soluble Polyphenols: Potential Role in Prevention and Treatment of Melanoma.

Heenatigala Palliyage G, Singh S, Ashby CR Jr, Tiwari AK, Chauhan H.

AAPS PharmSciTech. 2019 Jul 11;20(6):250. doi: 10.1208/s12249-019-1457-1. Review.

PMID:
31297635
5.

Novel 3-((2-chloroquinolin-3-yl)methylene)indolin-2-one derivatives produce anticancer efficacy in ovarian cancer in vitro.

Karthikeyan C, Amawi H, Ashby CR Jr, Khare VM, Jones V, Hari Narayana Moorthy NS, Trivedi P, Tiwari AK.

Heliyon. 2019 May 14;5(5):e01603. doi: 10.1016/j.heliyon.2019.e01603. eCollection 2019 May.

6.

Novel Thienopyrimidine Derivative, RP-010, Induces β-Catenin Fragmentation and Is Efficacious against Prostate Cancer Cells.

Amawi H, Hussein N, Boddu SHS, Karthikeyan C, Williams FE, Ashby CR Jr, Raman D, Trivedi P, Tiwari AK.

Cancers (Basel). 2019 May 23;11(5). pii: E711. doi: 10.3390/cancers11050711.

7.

The targeting of non‑coding RNAs by curcumin: Facts and hopes for cancer therapy (Review).

Liu Y, Sun H, Makabel B, Cui Q, Li J, Su C, Ashby CR Jr, Chen Z, Zhang J.

Oncol Rep. 2019 Jul;42(1):20-34. doi: 10.3892/or.2019.7148. Epub 2019 May 3.

8.

An organoruthenium complex overcomes ABCG2-mediated multidrug resistance via multiple mechanisms.

Zeng L, Li J, Zhang C, Zhang YK, Zhang W, Huang J, Ashby CR, Chen ZS, Chao H.

Chem Commun (Camb). 2019 Mar 26;55(26):3833-3836. doi: 10.1039/c9cc00882a.

PMID:
30869688
9.

Immune tolerance attenuates gut dysbiosis, dysregulated uterine gene expression and high-fat diet potentiated preterm birth in mice.

Manuel CR, Latuga MS, Ashby CR Jr, Reznik SE.

Am J Obstet Gynecol. 2019 Jun;220(6):596.e1-596.e28. doi: 10.1016/j.ajog.2019.02.028. Epub 2019 Feb 18.

PMID:
30790568
10.

Modulating ROS to overcome multidrug resistance in cancer.

Cui Q, Wang JQ, Assaraf YG, Ren L, Gupta P, Wei L, Ashby CR Jr, Yang DH, Chen ZS.

Drug Resist Updat. 2018 Nov;41:1-25. doi: 10.1016/j.drup.2018.11.001. Epub 2018 Nov 14. Review.

PMID:
30471641
11.

Cytokine gene expression following RSV-A infection.

Khare VM, Saxena VK, Tomar A, Nyinawabera A, Singh KB, Ashby CR Jr, Tiwari AK.

Front Biosci (Landmark Ed). 2019 Jan 1;24:463-481.

PMID:
30468667
12.

Sofosbuvir: A Potential Treatment for Ebola.

Reznik SE, Tiwari AK, Ashby CR Jr.

Front Pharmacol. 2018 Oct 10;9:1139. doi: 10.3389/fphar.2018.01139. eCollection 2018. No abstract available.

13.

Cariprazine, A Dopamine D₂/D₃ Receptor Partial Agonist, Modulates ABCG2-Mediated Multidrug Resistance in Cancer.

Hussein N, Ashby CR Jr, Amawi H, Nyinawabera A, Vij A, Khare VM, Karthikeyan C, Tiwari AK.

Cancers (Basel). 2018 Sep 4;10(9). pii: E308. doi: 10.3390/cancers10090308.

14.

Modulation of the ATP-Binding Cassette B1 Transporter by Neuro-Inflammatory Cytokines: Role in the Pathogenesis of Alzheimer's Disease.

Alasmari F, Ashby CR Jr, Hall FS, Sari Y, Tiwari AK.

Front Pharmacol. 2018 Jun 20;9:658. doi: 10.3389/fphar.2018.00658. eCollection 2018. No abstract available.

15.

Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and Metastasis.

Amawi H, Hussein NA, Ashby CR Jr, Alnafisah R, Sanglard LM, Manivannan E, Karthikeyan C, Trivedi P, Eisenmann KM, Robey RW, Tiwari AK.

Front Pharmacol. 2018 May 23;9:520. doi: 10.3389/fphar.2018.00520. eCollection 2018.

16.

lH-Pyrazolo[3,4-b]quinolin-3-amine derivatives inhibit growth of colon cancer cells via apoptosis and sub G1 cell cycle arrest.

Karthikeyan C, Amawi H, Viana AG, Sanglard L, Hussein N, Saddler M, Ashby CR Jr, Moorthy NSHN, Trivedi P, Tiwari AK.

Bioorg Med Chem Lett. 2018 Jul 15;28(13):2244-2249. doi: 10.1016/j.bmcl.2018.05.045. Epub 2018 May 24.

PMID:
29853331
17.

Saturated and unsaturated fatty acids differentially regulate in vitro and ex vivo placental antioxidant capacity.

Manuel CR, Charron MJ, Ashby CR Jr, Reznik SE.

Am J Reprod Immunol. 2018 Sep;80(3):e12868. doi: 10.1111/aji.12868. Epub 2018 May 7.

PMID:
29736947
18.

The novel atypical antipsychotic cariprazine demonstrates dopamine D2 receptor-dependent partial agonist actions on rat mesencephalic dopamine neuronal activity.

Delcourte S, Ashby CR Jr, Rovera R, Kiss B, Adham N, Farkas B, Haddjeri N.

CNS Neurosci Ther. 2018 Dec;24(12):1129-1139. doi: 10.1111/cns.12867. Epub 2018 May 4.

19.

Selective dopamine D3 receptor antagonism significantly attenuates stress-induced immobility in a rat model of post-traumatic stress disorder.

Rice OV, Ashby CR Jr, Dixon C, Laurenzo W, Hayden J, Song R, Li J, Tiwari AK, Gardner EL.

Synapse. 2018 Aug;72(8):e22035. doi: 10.1002/syn.22035. Epub 2018 Jun 7.

20.

Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo.

Zhang GN, Zhang YK, Wang YJ, Gupta P, Ashby CR Jr, Alqahtani S, Deng T, Bates SE, Kaddoumi A, Wurpel JND, Lei YX, Chen ZS.

Cancer Lett. 2018 Jun 28;424:19-29. doi: 10.1016/j.canlet.2018.02.040. Epub 2018 Mar 5.

PMID:
29518481

Supplemental Content

Loading ...
Support Center